(Q44777668)

English

Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease

scientific article published in March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

0 references

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lee BJ

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Huang MC

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Chung LJ

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Cheng CH

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Lin KL

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Su KH

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Huang YC

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

European Journal of Clinical Nutrition

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

481-487

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1601834

0 references

Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

Plasma folate but not vitamin B(12) or homocysteine concentrations are reduced after short-term vitamin B(6) supplementation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

Homocysteine, vitamin B(6), and lipid in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

Plasma homocyst(e)ine levels in men with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

Homocysteine and risk of coronary artery disease: Folate is the important determinant of plasma homocysteine concentration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

Serum Folate and Risk of Fatal Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

The effect of folic acid supplementation on plasma homocysteine in an elderly population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

The effect of a subnormal vitamin B-6 status on homocysteine metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

21 January 2018

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitamin B-12 status is inversely associated with plasma homocysteine in young women with C677T and/or A1298C methylenetetrahydrofolate reductase polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple, sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma total homocysteine response to oral doses of folic acid and pyridoxine hydrochloride (vitamin B6) in healthy individuals. Oral doses of vitamin B6reduce concentrations of serum folate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma pyridoxal-5-phosphate level as risk index for coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitamin requirements for the treatment of hyperhomocysteinemia in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Pyridoxine Supplementation on Glutamic-Pyruvic Transaminase and In Vitro Stimulation in Erythrocytes of Normal Women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601834

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.EJCN.1601834

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44777668&oldid=2040333423"